Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-25-000101
Filing Date
2025-08-14
Accepted
2025-08-14 16:06:06
Documents
57
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20250630.htm   iXBRL 10-Q 852575
2 EX-10.1 exhibit10-1royaltypurchase.htm EX-10.1 486197
3 EX-31.1 exhibit31-1q22025.htm EX-31.1 8930
4 EX-31.2 exhibit31-2q22025.htm EX-31.2 8923
5 EX-32.1 exhibit32-1q22025.htm EX-32.1 3914
6 EX-32.2 exhibit32-2q22025.htm EX-32.2 3770
  Complete submission text file 0001125345-25-000101.txt   5660033

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20250630.xsd EX-101.SCH 35920
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20250630_cal.xml EX-101.CAL 45072
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20250630_def.xml EX-101.DEF 194435
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20250630_lab.xml EX-101.LAB 519657
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20250630_pre.xml EX-101.PRE 354035
59 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20250630_htm.xml XML 642319
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 251218829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)